Determinants of disability in multiple sclerosis: An immunological and MRI study

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Tortorella, Paola ^a   Laganà, Maria Marcella ^a   Saresella, Marina ^a   Tavazzi, Eleonora ^a   Preti, Maria Giulia ^a,b   Ricci, Cristian ^a,c   Baglio, Francesca ^a   Marventano, Ivana ^a   Piancone, Federica ^a   Baselli, Giuseppe ^b   Cecconi, Pietro ^a   Caputo, Domenico ^a   Clerici, Mario ^a   Rovaris, Marco ^a  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b POLITECNICO DI MILANO   (Italy)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON; BIOLOGICAL MARKER; CONTRAST MEDIUM; GLATIRAMER; INTERFERON BETA SERINE; CYTOKINE;

ADULT; ARTICLE; BRAIN SIZE; CD14 IL6 T LYMPHOCYTE; CD4 IL25 T LYMPHOCYTE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISABILITY; FEMALE; FRACTIONAL ANISOTROPY; GRAY MATTER; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL BLOOD MONONUCLEAR CELL; PYRAMIDAL TRACT; T LYMPHOCYTE; BIOSYNTHESIS; CASE CONTROL STUDY; DEMOGRAPHY; DIFFUSION WEIGHTED IMAGING; IMMUNOLOGY; MIDDLE AGED; PHENOTYPE;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; DEMOGRAPHY; DIFFUSION MAGNETIC RESONANCE IMAGING; DISABILITY EVALUATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PHENOTYPE;

EID: 84900021164     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/875768     Document Type: Article

References (39)

1. Kremenchutzky M., Rice G. P. A., Baskerville J., Wingerchuk D. M., Ebers G. C., The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain 2006 129 3 584 594 2-s2.0-33244486947 10.1093/brain/awh721
2. Ramsaransing G. S. M., de Keyser J., Benign course in multiple sclerosis: a review. Acta Neurologica Scandinavica 2006 113 6 359 369 2-s2.0-33745884406 10.1111/j.1600-0404.2006.00637.x
3. Sayao A.-L., Devonshire V., Tremlett H., Longitudinal follow-up of "benign" multiple sclerosis at 20 years. Neurology 2007 68 7 496 500 2-s2.0-33847068763 10.1212/01.wnl.0000253185.03943.66
4. Rovaris M., Barkhof F., Calabrese M., de Stefano N., Fazekas F., Miller D. H., Montalban X., Polman C., Rocca M. A., Thompson A. J., Yousry T. A., Filippi M., MRI features of benign multiple sclerosis Toward a new definition of this disease phenotype. Neurology 2009 72 19 1693 1701 2-s2.0-67049100681 10.1212/WNL.0b013e3181a55feb
5. Calabrese M., Favaretto A., Poretto V., Romualdi C., Rinaldi F., Mattisi I., Morra A., Perini P., Gallo P., Low degree of cortical pathology is associated with benign course of multiple sclerosis. Multiple Sclerosis 2012 19 904 911
6. Gauthier S. A., Berger A. M., Liptak Z., Duan Y., Egorova S., Buckle G. J., Glanz B. I., Khoury S. J., Bakshi R., Weiner H. L., Guttmann C. R. G., Rate of brain atrophy in benign vs early multiple sclerosis. Archives of Neurology 2009 66 2 234 237 2-s2.0-60549086125 10.1001/archneurol.2008.567
7. Calabrese M., Poretto V., Favaretto A., Alessio S., Bernardi V., Romualdi C., Rinaldi F., Perini P., Gallo P., Cortical lesion load associates with progression of disability in multiple sclerosis. Brain 2012 135 2952 2961
8. Shiee N., Bazin P. L., Zackowski K. M., Farrell S. K., Harrison D. M., Newsome S. D., Ratchford J. N., Caffo B. S., Calabresi P. A., Pham D. L., Reich D. S., Revisiting brain atrophy and its relationship to disability in multiple sclerosis. PLoS ONE 2012 7 e37049
9. Harrison D. M., Shiee N., Bazin P. L., Newsome S. D., Ratchford J. N., Pham D., Calabresi P. A., Reich D. S., Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis. Journal of Neurology 2012 260 397 406
10. Sigal T., Shmuel M., Mark D., Gil H., Anat A., Diffusion tensor imaging of corpus callosum integrity in multiple sclerosis: correlation with disease variables. Journal of Neuroimaging 2012 22 1 33 37 2-s2.0-84855918491 10.1111/j.1552-6569.2010.00556.x
11. Amedei A., Prisco D., D'Elios M. M., Multiple sclerosis: the role of cytokines in pathogenesis and in therapies. International Journal of Molecular Sciences 2012 13 13438 13460
12. Sørensen T. L., Sellebjerg F., Distinct chemokine receptor and cytokine expression profile in secondary progressive MS. Neurology 2001 57 8 1371 1376 2-s2.0-18544404188
13. Polman C. H., Reingold S. C., Edan G., Filippi M., Hartung H. P., Kappos L., Lublin F. D., Metz L. M., McFarland H. F., O'Connor P. W., Sandberg-Wollheim M., Thompson A. J., Weinshenker B. G., Wolinsky J. S., Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Annals of Neurology 2005 58 6 840 846 2-s2.0-28544436950 10.1002/ana.20703
14. Kurtzke J. F., Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983 33 11 1444 1452 2-s2.0-0021035886
15. Lublin F. D., Reingold S. C., Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996 46 4 907 911 2-s2.0-0029913882
16. Laganà M. M., Ceccarelli A., Preti M. G., Venturelli C., Sormani M. P., Cavarretta R., Baselli G., Cecconi P., Caputo D., Rovaris M., Atlas-based versus individual-based fiber tracking of the corpus callosum in patients with multiple sclerosis: reliability and clinical correlations. Journal of Neuroimaging 2012 22 355 364 2-s2.0-80053451333 10.1111/j.1552-6569.2011.00650.x
17. Smith S. M., de Stefano N., Jenkinson M., Matthews P. M., Normalized accurate measurement of longitudinal brain change. Journal of Computer Assisted Tomography 2001 25 3 466 475 2-s2.0-0035006178 10.1097/00004728-200105000-00022
18. Hua K., Zhang J., Wakana S., Jiang H., Li X., Reich D. S., Calabresi P. A., Pekar J. J., van Zijl P. C. M., Mori S., Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. NeuroImage 2008 39 1 336 347 2-s2.0-36048983778 10.1016/j.neuroimage.2007.07.053
19. Reich D. S., Ozturk A., Calabresi P. A., Mori S., Automated vs. conventional tractography in multiple sclerosis: Variability and correlation with disability. NeuroImage 2010 49 4 3047 3056 2-s2.0-73749086028 10.1016/j.neuroimage.2009.11.043
20. Saresella M., Calabrese E., Marventano I., Piancone F., Gatti A., Alberoni M., Nemni R., Clerici M., Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer's disease. Brain, Behavior, and Immunity 2011 25 3 539 547 2-s2.0-79551687962 10.1016/j.bbi.2010.12.004
21. Fisher R. A., On the probable error of a coefficient of correlation deduced from a small sample. Metron 1921 1 3 32
22. Blom G., Statistical Estimates and Transformed Beta-Variables 1958 New York, NY, USA John Wiley & Sons
23. Kramer C. Y., Extension of multiple range tests to group means with unequal numbers of replications. Biometrics 1956 12 307 310
24. Saresella M., Marventano I., Guerini F. R., Zanzottera M., Delbue S., Marchioni E., Maserati R., Longhi R., Ferrante P., Clerici M., Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseases. Clinical Immunology 2008 129 3 509 517 2-s2.0-55249115302 10.1016/j.clim.2008.08.010
25. Bergsland N., Horakova D., Dwyer M. G., Dolezal O., Seidl Z. K., Vaneckova M., Krasensky J., Havrdova E., Zivadinov R., Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. American Journal of Neuroradiology 2012 33 1573 1578
26. Portaccio E., Stromillo M. L., Goretti B., Zipoli V., Siracusa G., Battaglini M., Giorgio A., Bartolozzi M. L., Guidi L., Sorbi S., Federico A., Amato M. P., de Stefano N., Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology 2009 73 7 498 503 2-s2.0-69449093937 10.1212/WNL.0b013e3181b351fd
27. Charil A., Zijdenbos A. P., Taylor J., Boelman C., Worsley K. J., Evans A. C., Dagher A., Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. NeuroImage 2003 19 3 532 544 2-s2.0-0042671368 10.1016/S1053-8119(03) 00117-4
28. Hackmack K., Weygandt M., Wuerfel J., Pfueller C. F., Bellmann-Strobl J., Paul F., Haynes J. D., Can we overcome the "clinico-radiological paradox" in multiple sclerosis? Journal of Neurology 2012 259 2151 2160 2-s2.0-84858716452 10.1007/s00415-012-6475-9
29. Gorgoraptis N., Wheeler-Kingshott C. A. M., Jenkins T. M., Altmann D. R., Miller D. H., Thompson A. J., Ciccarelli O., Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis. Multiple Sclerosis 2010 16 5 555 565 2-s2.0-77952872227 10.1177/1352458510362440
30. Spanò B., Cercignani M., Basile B., Romano S., Mannu R., Centonze D., Caltagirone C., Bramanti P., Nocentini U., Bozzali M., Multiparametric MR investigation of the motor pyramidal system in patients with "truly benign" multiple sclerosis. Multiple Sclerosis 2010 16 2 178 188 2-s2.0-76449095769 10.1177/1352458509356010
31. Esendagli G., Kurne A. T., Sayat G., Kilic A. K., Guc D., Karabudak R., Evaluation of Th17-related cytokines and receptors in multiple sclerosis patients under interferon beta-1 therapy. Journal of Neuroimmunology 2012 255 81 84
32. Rovaris M., Confavreux C., Furlan R., Kappos L., Comi G., Filippi M., Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurology 2006 5 4 343 354 2-s2.0-33644974688 10.1016/S1474-4422(06)70410-0
33. Tubridy N., Coles A. J., Molyneux P., Compston D. A. S., Barkhof F., Thompson A. J., McDonald W. I., Miller D. H., Secondary progressive multiple sclerosis, the relationship between short-term MRI activity and clinical features. Brain 1998 121 2 225 231 2-s2.0-0031932589 10.1093/brain/121.2.225
34. La Mantia L., Vacchi L., Rovaris M., di Pietrantonj C., Ebers G., Fredrikson S., Filippini G., Interferon beta for secondary progressive multiple sclerosis: a systematic review. Journal of Neurology, Neurosurgery and Psychiatry 2012 84 420 426
35. Saresella M., Piancone F., Tortorella P., Marventano I., Gatti A., Caputo D., Lunetta C., Corbo M., Rovaris M., Clerici M., T helper-17 activation dominates the immunologic milieu of both amyotrophic lateral sclerosis and progressive multiple sclerosis. Clinical Immunology 2013 148 79 88
36. Wee Yong V., Inflammation in neurological disorders: a help or a hindrance? Neuroscientist 2010 16 4 408 420 2-s2.0-77956302879 10.1177/1073858410371379
37. Penkowa M., Moos T., Carrasco J., Hadberg H., Molinero A., Bluethmann H., Hidalgo J., Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice. Glia 1999 25 343 357
38. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Aloisi F., Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathology 2004 14 2 164 174 2-s2.0-2442708947
39. Magliozzi R., Howell O., Vora A., Serafini B., Nicholas R., Puopolo M., Reynolds R., Aloisi F., Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007 130 4 1089 1104 2-s2.0-34249700046 10.1093/brain/awm038